# Synchronous Overexpression of Epidermal Growth Factor Receptor and HER2-<b> <i>neu</i> </b> Protein Is a Predictor of Poor Outcome in Patients with Stage I Non-Small Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/synchronous-overexpression-of-epidermal-growth-factor-receptor-and-her2-b-i-neu/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Amir Onn,Arlene M. Correa,Michael Z. Gilcrease,Takeshi Isobe,Erminia Massarelli,Corazon D. Bucana,Michael S. O’Reilly,Waun Ki Hong,Isaiah J. Fidler,Joe B. Putnam,Roy S. Herbst |
| Citations | 136 |
| DOI | 10.1158/1078-0432.ccr-0373-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2145640226 |
| PMID | 14734462 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Amir Onn](https://scholariq.org/researchers/amir-onn/)

## Paper journal

- [Clinical Cancer Research](https://scholariq.org/journals/clinical-cancer-research/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.